| Q42829215 | 14-3-3ε couples protein kinase A to semaphorin signaling and silences plexin RasGAP-mediated axonal repulsion |
| Q53451849 | 6-Hydroxydopamine-induced PC12 cell death is mediated by MEF2D down-regulation. |
| Q64278585 | A Late Phase of Long-Term Synaptic Depression in Cerebellar Purkinje Cells Requires Activation of MEF2 |
| Q43149079 | A boost in microRNAs shapes up the neuron |
| Q24336107 | A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression |
| Q30245032 | A central role for calcineurin in protein misfolding neurodegenerative diseases. |
| Q46046510 | A hierarchical coherent-gene-group model for brain development. |
| Q37702729 | A replication study of GWAS findings in migraine identifies association in a Swedish case-control sample |
| Q37260150 | A retrograde neuronal survival response: target-derived neurotrophins regulate MEF2D and bcl-w |
| Q33756913 | A role for dendritic mGluR5-mediated local translation of Arc/Arg3.1 in MEF2-dependent synapse elimination |
| Q28282315 | AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro |
| Q38160667 | AMPA-silent synapses in brain development and pathology |
| Q37663170 | ATM-dependent phosphorylation of MEF2D promotes neuronal survival after DNA damage |
| Q30372906 | Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases |
| Q41481375 | Activating transcription factor 4 (ATF4) modulates post-synaptic development and dendritic spine morphology |
| Q35773964 | Activation of intracellular metabotropic glutamate receptor 5 in striatal neurons leads to up-regulation of genes associated with sustained synaptic transmission including Arc/Arg3.1 protein |
| Q57793727 | Activity-Regulated Transcription: Bridging the Gap between Neural Activity and Behavior |
| Q38074584 | Activity-dependent neuronal signalling and autism spectrum disorder |
| Q28510423 | Activity-dependent regulation of inhibitory synapse development by Npas4 |
| Q39858667 | Activity-dependent repression of Cbln1 expression: mechanism for developmental and homeostatic regulation of synapses in the cerebellum. |
| Q36713956 | Activity-induced protocadherin arcadlin regulates dendritic spine number by triggering N-cadherin endocytosis via TAO2beta and p38 MAP kinases |
| Q35607243 | Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. |
| Q27345329 | Adult Deletion of SRF Increases Epileptogenesis and Decreases Activity-Induced Gene Expression. |
| Q28069757 | Advancing the understanding of autism disease mechanisms through genetics |
| Q30596522 | Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome. |
| Q36063269 | Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease |
| Q47839926 | Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies. |
| Q48095306 | An Optimal Frequency in Ca2+ Oscillations for Stomatal Closure Is an Emergent Property of Ion Transport in Guard Cells. |
| Q35945470 | An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development. |
| Q37048054 | An epigenetic mechanism mediates developmental nicotine effects on neuronal structure and behavior. |
| Q98773451 | An essential role for MEF2C in the cortical response to loss of sleep in mice |
| Q90251211 | Antagonizing Increased miR-135a Levels at the Chronic Stage of Experimental TLE Reduces Spontaneous Recurrent Seizures |
| Q93165151 | Anxiolytic and Anxiogenic? How the Transcription Factor MEF2 Might Explain the Manifold Behavioral Effects of Oxytocin |
| Q46964980 | Arachidonic acid as a retrograde signal controlling growth and dynamics of retinotectal arbors. |
| Q27320813 | Autism-Associated Chromatin Regulator Brg1/SmarcA4 Is Required for Synapse Development and Myocyte Enhancer Factor 2-Mediated Synapse Remodeling |
| Q35182543 | Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases |
| Q38443141 | Biochemical Computation for Spine Structural Plasticity |
| Q37952382 | Biological pathways to adaptability--interactions between genome, epigenome, nervous system and environment for adaptive behavior |
| Q33638732 | Cabin1 expression suggests roles in neuronal development |
| Q40195503 | Cabin1 represses MEF2 transcriptional activity by association with a methyltransferase, SUV39H1. |
| Q42553916 | Calcineurin signaling mediates activity-dependent relocation of the axon initial segment |
| Q34203749 | Calcium signaling in synapse-to-nucleus communication |
| Q28586252 | Calcium-dependent dephosphorylation of the histone chaperone DAXX regulates H3.3 loading and transcription upon neuronal activation |
| Q35774086 | Calpain-mediated degradation of myocyte enhancer factor 2D contributes to excitotoxicity by activation of extrasynaptic N-methyl-D-aspartate receptors |
| Q41762924 | Cc2d1a, a C2 domain containing protein linked to nonsyndromic mental retardation, controls functional maturation of central synapses |
| Q50549989 | Cdk5 Regulates Activity-Dependent Gene Expression and Dendrite Development. |
| Q37323619 | Cell-intrinsic drivers of dendrite morphogenesis |
| Q55177515 | Circadian Plasticity in the Brain of Insects and Rodents. |
| Q37495863 | Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance |
| Q41941314 | Circadian pacemaker neurons change synaptic contacts across the day |
| Q28569311 | Cocaine induces the expression of MEF2C transcription factor in rat striatum through activation of SIK1 and phosphorylation of the histone deacetylase HDAC5 |
| Q34818266 | Cocaine regulates MEF2 to control synaptic and behavioral plasticity |
| Q37212202 | Communication between the synapse and the nucleus in neuronal development, plasticity, and disease |
| Q28505170 | Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex |
| Q36618285 | Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory. |
| Q33623164 | DREAM controls the on/off switch of specific activity-dependent transcription pathways |
| Q35500554 | Death-associated protein kinase phosphorylates mammalian ribosomal protein S6 and reduces protein synthesis |
| Q42145626 | Decoding the molecular evolution of human cognition using comparative genomics |
| Q88535420 | Dendritic Spine Elimination: Molecular Mechanisms and Implications |
| Q37858674 | Dentate gyrus neurogenesis, integration and microRNAs |
| Q48462051 | Differential effects of Ca2+ and cAMP on transcription mediated by MEF2D and cAMP-response element-binding protein in hippocampal neurons |
| Q28571349 | Differential effects of binge methamphetamine injections on the mRNA expression of histone deacetylases (HDACs) in the rat striatum |
| Q37185190 | Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? |
| Q39861257 | Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression. |
| Q34627156 | Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients |
| Q27313862 | Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration |
| Q41691925 | Distinct stages of synapse elimination are induced by burst firing of CA1 neurons and differentially require MEF2A/D |
| Q35652924 | Dynamic aspects of CNS synapse formation. |
| Q38322135 | Electrical activity can impose time of day on the circadian transcriptome of pacemaker neurons |
| Q36995104 | Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction |
| Q21558421 | Emerging role of non-coding RNA in neural plasticity, cognitive function, and neuropsychiatric disorders |
| Q38116091 | Emerging roles for MEF2 transcription factors in memory |
| Q49646234 | Emerging themes in neuronal activity-dependent gene expression |
| Q36412675 | Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons. |
| Q34575272 | Enrichment of conserved synaptic activity-responsive element in neuronal genes predicts a coordinated response of MEF2, CREB and SRF. |
| Q24304584 | EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation |
| Q42375076 | Ephecting Excitatory Synapse Development |
| Q64118600 | Ephrin-B3 controls excitatory synapse density through cell-cell competition for EphBs |
| Q28596593 | Evolution of Osteocrin as an activity-regulated factor in the primate brain |
| Q48434775 | Evolution: Genomic remodelling in the primate brain |
| Q47132310 | Experience-Dependent and Differential Regulation of Local and Long-Range Excitatory Neocortical Circuits by Postsynaptic Mef2c |
| Q28730816 | Extension of cortical synaptic development distinguishes humans from chimpanzees and macaques |
| Q39063317 | FMRP-dependent Mdm2 dephosphorylation is required for MEF2-induced synapse elimination |
| Q40220770 | FMRP: a triple threat to PSD-95. |
| Q27312401 | Feeding state, insulin and NPR-1 modulate chemoreceptor gene expression via integration of sensory and circuit inputs |
| Q28590430 | FoxO6 regulates memory consolidation and synaptic function |
| Q37372489 | Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c |
| Q40372504 | Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. |
| Q33738812 | Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration |
| Q36068950 | Functional Interactions between Mammalian Respiratory Rhythmogenic and Premotor Circuitry. |
| Q84766369 | Functional gene expression analysis of tissue-specific isoforms of Mef2c |
| Q36523920 | Generation of neuronal variability and complexity |
| Q34689960 | Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models |
| Q33348860 | Genetics and cell biology of building specific synaptic connectivity |
| Q36738343 | Genome-Wide Association and Exome Sequencing Study of Language Disorder in an Isolated Population |
| Q37070840 | Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection |
| Q29416996 | Genome-wide association analysis identifies susceptibility loci for migraine without aura |
| Q39328196 | Genome-wide epigenetic analysis of MEF2A and MEF2C transcription factors in mouse cortical neurons |
| Q61818064 | Genomic Enhancers in Brain Health and Disease |
| Q26782959 | Genomic Views of Transcriptional Enhancers: Essential Determinants of Cellular Identity and Activity-Dependent Responses in the CNS |
| Q36147160 | Glucocorticoid receptor and myocyte enhancer factor 2 cooperate to regulate the expression of c-JUN in a neuronal context |
| Q41209497 | HDAC4 governs a transcriptional program essential for synaptic plasticity and memory |
| Q36823712 | Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections |
| Q37809823 | Hippocampal gene profiling: toward a systems biology of the hippocampus |
| Q24673733 | Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2 |
| Q33956241 | Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function |
| Q36941500 | Histone methyltransferase Ash1L mediates activity-dependent repression of neurexin-1α. |
| Q26829142 | Histone regulation in the CNS: basic principles of epigenetic plasticity |
| Q30477767 | How the timing and quality of early experiences influence the development of brain architecture |
| Q37584846 | How voltage-gated calcium channels gate forms of homeostatic synaptic plasticity |
| Q34322973 | Human brain evolution: transcripts, metabolites and their regulators |
| Q38070687 | Human studies in the pathophysiology of migraine: genetics and functional neuroimaging |
| Q48462977 | IGF-1 deficiency causes atrophic changes associated with upregulation of VGluT1 and downregulation of MEF2 transcription factors in the mouse cochlear nuclei. |
| Q24655308 | Identifying autism loci and genes by tracing recent shared ancestry |
| Q38550206 | Immune mediators in the brain and peripheral tissues in autism spectrum disorder |
| Q37564195 | Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models |
| Q28508411 | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival |
| Q34435526 | Increasing our understanding of human cognition through the study of Fragile X Syndrome |
| Q46673204 | Indirubin-3-Oxime Effectively Prevents 6OHDA-Induced Neurotoxicity in PC12 Cells via Activating MEF2D Through the Inhibition of GSK3β. |
| Q36299874 | Inducible knockout of Mef2a, -c, and -d from nestin-expressing stem/progenitor cells and their progeny unexpectedly uncouples neurogenesis and dendritogenesis in vivo |
| Q28571273 | Interaction between autism-linked MDGAs and neuroligins suppresses inhibitory synapse development |
| Q27023529 | Interactions between mitochondria and the transcription factor myocyte enhancer factor 2 (MEF2) regulate neuronal structural and functional plasticity and metaplasticity |
| Q42598014 | Intrinsic programs regulating dendrites and synapses in the upper layer neurons of the cortex |
| Q28513918 | Inverse synaptic tagging of inactive synapses via dynamic interaction of Arc/Arg3.1 with CaMKIIβ |
| Q35059263 | Isoform-specific dephosphorylation of dynamin1 by calcineurin couples neurotrophin receptor endocytosis to axonal growth |
| Q35612504 | KIN-29 SIK regulates chemoreceptor gene expression via an MEF2 transcription factor and a class II HDAC. |
| Q45802577 | LINC00461, a long non-coding RNA, is important for the proliferation and migration of glioma cells |
| Q34425226 | LTP‐ and LTD‐inducing stimulations cause opposite changes in arc/arg3.1 mRNA level in hippocampal area CA1 in vivo |
| Q36152269 | Learning to see: patterned visual activity and the development of visual function |
| Q37295248 | Localization of myocyte enhancer factor 2 in the rodent forebrain: regionally-specific cytoplasmic expression of MEF2A |
| Q37076788 | Long-Term Memory in Drosophila Is Influenced by Histone Deacetylase HDAC4 Interacting with SUMO-Conjugating Enzyme Ubc9. |
| Q48183034 | Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice. |
| Q40817289 | MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. |
| Q30557593 | MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation |
| Q48411990 | MEF2 negatively regulates learning-induced structural plasticity and memory formation |
| Q26778515 | MEF2 transcription factors: developmental regulators and emerging cancer genes |
| Q52626735 | MEF2A regulates mGluR-dependent AMPA receptor trafficking independently of Arc/Arg3.1. |
| Q97884887 | MEF2C and HDAC5 regulate Egr1 and Arc genes to increase dendritic spine density and complexity in early enriched environment |
| Q27322685 | MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model |
| Q33766816 | MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations |
| Q47578844 | MEF2C mRNA expression and cognitive function in Japanese patients with Alzheimer's disease. |
| Q30370553 | MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders. |
| Q37457424 | MEF2C rs190982 polymorphism with late-onset Alzheimer's disease in Han Chinese: A replication study and meta-analyses |
| Q45051337 | MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice. |
| Q28507026 | MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function |
| Q39515862 | MEF2D drives photoreceptor development through a genome-wide competition for tissue-specific enhancers |
| Q35744568 | MHC class I limits hippocampal synapse density by inhibiting neuronal insulin receptor signaling |
| Q35652867 | MHCI negatively regulates synapse density during the establishment of cortical connections. |
| Q37128147 | MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease |
| Q37157163 | MRF4 negatively regulates adult skeletal muscle growth by repressing MEF2 activity |
| Q27321664 | MTM-6, a phosphoinositide phosphatase, is required to promote synapse formation in Caenorhabditis elegans |
| Q89636598 | Mechanism for neurotransmitter-receptor matching |
| Q35100259 | Mechanisms of specificity in neuronal activity-regulated gene transcription |
| Q88565654 | Mef2 induction of the immediate early gene Hr38/Nr4a is terminated by Sirt1 to promote ethanol tolerance |
| Q43079834 | Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels |
| Q36367305 | Members of the myocyte enhancer factor 2 transcription factor family differentially regulate Bdnf transcription in response to neuronal depolarization |
| Q90581905 | Memory corticalization triggered by REM sleep: mechanisms of cellular and systems consolidation |
| Q42627275 | MicroRNA as modulators of neuronal responses |
| Q37012051 | MicroRNAs in synapse development: tiny molecules to remember |
| Q33813237 | Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex |
| Q38126970 | Migraine genetics: Part II. |
| Q39077188 | Migraine genetics: current findings and future lines of research |
| Q38286465 | Migraine pathophysiology: lessons from mouse models and human genetics |
| Q36367283 | Modulation of striatal projection systems by dopamine |
| Q38541790 | Molecular Genetic Strategies in the Study of Corticohippocampal Circuits |
| Q35855413 | Molecular cloning and in silico analysis of the duck (Anas platyrhynchos) MEF2A gene cDNA and its expression profile in muscle tissues during fetal development |
| Q26851882 | Molecular mechanisms of activity-dependent changes in dendritic morphology: role of RGK proteins |
| Q37276949 | Molecular mechanisms underlying neural circuit formation |
| Q24306675 | Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95 |
| Q90317190 | Muscle A-kinase-anchoring protein-β-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D |
| Q90631344 | Myocyte Enhancer Factor 2A (MEF2A) Defines Oxytocin-Induced Morphological Effects and Regulates Mitochondrial Function in Neurons |
| Q57059733 | Myocyte Enhancer Factor 2c Regulates Dendritic Complexity and Connectivity of Cerebellar Purkinje Cells |
| Q36749194 | Myocyte enhancer factor 2A is transcriptionally autoregulated |
| Q28591351 | Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells |
| Q40463837 | Myocyte-specific enhancer binding factor 2A expression is downregulated during temporal lobe epilepsy. |
| Q38815284 | Myosin II activity is required for structural plasticity at the axon initial segment |
| Q28585774 | Nemo-like kinase-myocyte enhancer factor 2A signaling regulates anterior formation in Xenopus development |
| Q35663493 | Network activity-independent coordinated gene expression program for synapse assembly. |
| Q35847970 | NeuroD2 regulates the development of hippocampal mossy fiber synapses |
| Q64076560 | Neuroglial Involvement in Abnormal Glutamate Transport in the Cochlear Nuclei of the Igf1−/− Mouse |
| Q47279488 | Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders |
| Q41896172 | Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex |
| Q92668133 | Neuronal Myocyte-Specific Enhancer Factor 2D (MEF2D) Is Required for Normal Circadian and Sleep Behavior in Mice |
| Q34295237 | Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction |
| Q34183712 | Neuronal activity-regulated gene transcription in synapse development and cognitive function |
| Q90725360 | Neuroprotection Against MPP+-Induced Cytotoxicity Through the Activation of PI3-K/Akt/GSK3β/MEF2D Signaling Pathway by Rhynchophylline, the Major Tetracyclic Oxindole Alkaloid Isolated From Uncaria rhynchophylla |
| Q34377554 | Neuroprotective activity of pDING in response to HIV-1 Tat. |
| Q36074224 | Neuroprotective effects of Paeonia Lactiflora extract against cell death of dopaminergic SH-SY5Y cells is mediated by epigenetic modulation. |
| Q46325053 | Neuroscience: Brain's defence against cocaine |
| Q39319409 | Neurotoxin-induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress response |
| Q26784157 | New Insights on Retrieval-Induced and Ongoing Memory Consolidation: Lessons from Arc |
| Q46098319 | NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism |
| Q42672709 | Normal dendrite growth in Drosophila motor neurons requires the AP-1 transcription factor |
| Q43880695 | Novel role and regulation of HDAC4 in cocaine-related behaviors |
| Q33816003 | Nr4a1-eGFP is a marker of striosome-matrix architecture, development and activity in the extended striatum |
| Q89602927 | Nuclear receptor corepressors in intellectual disability and autism |
| Q41075517 | Nucleocytoplasmic Shuttling of Histone Deacetylase 9 Controls Activity-Dependent Thalamocortical Axon Branching |
| Q34711683 | Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. |
| Q41288601 | Oleanolic Acid Promotes Neuronal Differentiation and Histone Deacetylase 5 Phosphorylation in Rat Hippocampal Neurons |
| Q36017267 | Oxytocin Regulates Stress-Induced Crf Gene Transcription through CREB-Regulated Transcription Coactivator 3 |
| Q28566410 | PIASx is a MEF2 SUMO E3 ligase that promotes postsynaptic dendritic morphogenesis |
| Q33643260 | Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif |
| Q38371636 | Plasticity-related microRNA and their potential contribution to the maintenance of long-term potentiation |
| Q39999607 | Postnatal Loss of Mef2c Results in Dissociation of Effects on Synapse Number and Learning and Memory |
| Q37025074 | Postsynaptic FMRP bidirectionally regulates excitatory synapses as a function of developmental age and MEF2 activity. |
| Q38736600 | Posttranslational Modifications Regulate the Postsynaptic Localization of PSD-95. |
| Q36045416 | Potent Protection Against MPP(+)-Induced Neurotoxicity via Activating Transcription Factor MEF2D by a Novel Derivative of Naturally Occurring Danshensu/Tetramethylpyrazine |
| Q35299587 | Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells |
| Q55408929 | Prior activity of olfactory receptor neurons is required for proper sensory processing and behavior in Drosophila larvae. |
| Q34251153 | Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells. |
| Q37952957 | Protein SUMOylation in spine structure and function |
| Q24632495 | Protein phosphatases and Alzheimer's disease |
| Q35914303 | Quantitative expression profiling of identified neurons reveals cell-specific constraints on highly variable levels of gene expression. |
| Q39872809 | RSY-1 is a local inhibitor of presynaptic assembly in C. elegans |
| Q38128213 | Receptor trafficking and the regulation of synaptic plasticity by SUMO. |
| Q33500841 | Reciprocal regulation of microRNA and mRNA profiles in neuronal development and synapse formation |
| Q30495151 | Reduced cortical BDNF expression and aberrant memory in Carf knock-out mice |
| Q36529898 | Regulation of brain-derived neurotrophic factor expression in neurons |
| Q37986650 | Regulation of the actin cytoskeleton in dendritic spines |
| Q36754113 | Regulator of calmodulin signaling knockout mice display anxiety-like behavior and motivational deficits |
| Q50078213 | Rem2 signaling affects neuronal structure and function in part by regulation of gene expression. |
| Q48216131 | Retrograde Synaptic Inhibition Is Mediated by α-Neurexin Binding to the α2δ Subunits of N-Type Calcium Channels. |
| Q37835965 | Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress |
| Q34563274 | Role of salt-inducible kinase 1 in the activation of MEF2-dependent transcription by BDNF |
| Q47752204 | Roles for Arc in metabotropic glutamate receptor-dependent LTD and synapse elimination: Implications in health and disease |
| Q38295325 | S-Nitrosylation in neurogenesis and neuronal development |
| Q42173481 | S-nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell death |
| Q39229777 | SENP2 regulates MEF2A de-SUMOylation in an activity dependent manner |
| Q34865655 | SUMO modification of cell surface Kv2.1 potassium channels regulates the activity of rat hippocampal neurons |
| Q97884803 | SUMOylation and calcium signalling: potential roles in the brain and beyond |
| Q28568817 | SUMOylation of the MAGUK protein CASK regulates dendritic spinogenesis |
| Q22251430 | Searching for ways out of the autism maze: genetic, epigenetic and environmental clues |
| Q28728766 | Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy |
| Q47852385 | Selective inhibition of miR-92 in hippocampal neurons alters contextual fear memory |
| Q37078750 | Signaling by synaptogenic molecules. |
| Q24650727 | Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system |
| Q48215083 | Signaling via dopamine D1 and D3 receptors oppositely regulates cocaine-induced structural remodeling of dendrites and spines |
| Q55287009 | Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene. |
| Q35002793 | Spine growth in the anterior cingulate cortex is necessary for the consolidation of contextual fear memory |
| Q34502652 | Stimulus-specific combinatorial functionality of neuronal c-fos enhancers |
| Q27666773 | Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly |
| Q27659516 | Structure of the MADS-box/MEF2 Domain of MEF2A Bound to DNA and Its Implication for Myocardin Recruitment |
| Q37086805 | Sumoylated MEF2A coordinately eliminates orphan presynaptic sites and promotes maturation of presynaptic boutons. |
| Q26747536 | Sumoylation in Synaptic Function and Dysfunction |
| Q48808965 | Sumoylation of FOXP2 Regulates Motor Function and Vocal Communication Through Purkinje Cell Development |
| Q28587748 | Sumoylation regulates nuclear localization of lipin-1alpha in neuronal cells |
| Q48646891 | Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons. |
| Q37068389 | Synaptic activity-responsive element in the Arc/Arg3.1 promoter essential for synapse-to-nucleus signaling in activated neurons. |
| Q37431274 | Synaptic cross-talk between N-methyl-D-aspartate receptors and LAPSER1-beta-catenin at excitatory synapses |
| Q41534293 | Synaptic dysregulation in a human iPS cell model of mental disorders |
| Q37728628 | Targets and consequences of protein SUMOylation in neurons. |
| Q33744301 | The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. |
| Q88111421 | The Arc of cognition: Signaling cascades regulating Arc and implications for cognitive function and disease |
| Q64078884 | The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions |
| Q37020202 | The Drosophila transcription factor Adf-1 (nalyot) regulates dendrite growth by controlling FasII and Staufen expression downstream of CaMKII and neural activity |
| Q36182197 | The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation |
| Q38080479 | The MEF2 family and the brain: from molecules to memory |
| Q36249548 | The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice |
| Q35313641 | The Mef2A transcription factor coordinately regulates a costamere gene program in cardiac muscle |
| Q38671721 | The Role of CREB, SRF, and MEF2 in Activity-Dependent Neuronal Plasticity in the Visual Cortex. |
| Q33626781 | The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness. |
| Q48218228 | The effects of p-chloroamphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (ecstasy) on the gene expression of cytoskeletal proteins in the rat brain |
| Q91942357 | The first year |
| Q33686078 | The function of activity-regulated genes in the nervous system. |
| Q24339037 | The human language-associated gene SRPX2 regulates synapse formation and vocalization in mice |
| Q24644466 | The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions |
| Q38220786 | The neuronal activity-driven transcriptome. |
| Q24642383 | The regulation of dendritic arbor development and plasticity by glutamatergic synaptic input: a review of the synaptotrophic hypothesis |
| Q34775116 | The role of Cdk5 in cognition and neuropsychiatric and neurological pathology |
| Q40663529 | The role of dopamine in modulating the structure and function of striatal circuits. |
| Q33868039 | The serum response factor and a putative novel transcription factor regulate expression of the immediate-early gene Arc/Arg3.1 in neurons. |
| Q55314869 | The transcription factor MEF2A plays a key role in the differentiation/maturation of rat neural stem cells into neurons. |
| Q33878539 | The transcription factor Mef2 is required for normal circadian behavior in Drosophila |
| Q37382974 | The transcription factor Mef2 links the Drosophila core clock to Fas2, neuronal morphology, and circadian behavior |
| Q54254308 | The tumor suppressor p53 guides GluA1 homeostasis through Nedd4-2 during chronic elevation of neuronal activity. |
| Q39296630 | Transcribing the connectome: roles for transcription factors and chromatin regulators in activity-dependent synapse development |
| Q24644531 | Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo |
| Q88801150 | Transcriptional Regulation Involved in Fear Memory Reconsolidation |
| Q34222337 | Transcriptional regulation of neuronal polarity and morphogenesis in the mammalian brain |
| Q36799115 | Transcriptional regulation of vertebrate axon guidance and synapse formation |
| Q33613299 | Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc. |
| Q34249424 | Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action |
| Q37393562 | Transducing neuronal activity into dendritic spine morphology: new roles for p38 MAP kinase and N-cadherin |
| Q37078049 | Translating neuronal activity into dendrite elaboration: signaling to the nucleus |
| Q37215418 | Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner |
| Q34071838 | VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2C |
| Q26864720 | Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders |
| Q39006186 | Whole genome sequence study of cannabis dependence in two independent cohorts |
| Q41974605 | cJun integrates calcium activity and tlx3 expression to regulate neurotransmitter specification |
| Q58772354 | is essential for normal mushroom body and wing development |
| Q36458992 | mef2 activity levels differentially affect gene expression during Drosophila muscle development |
| Q34405175 | miRNA regulation of gene expression: a predictive bioinformatics analysis in the postnatally developing monkey hippocampus |
| Q100157936 | p-S133 CREB1, MEF2D and SRF bind the ARC gene |
| Q84979636 | α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease |
| Q28266190 | β-Hydroxy-β-Methylbutyrate (HMB) Promotes Neurite Outgrowth in Neuro2a Cells |